Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06668935 · ClinicalTrials.gov registry record
Prolongation of GLP-1 Adherence When Using Continuous Glucose Monitoring
A clinical trial of Diabetes Mellitus, sponsored by Abbott Diabetes Care.
- Recruiting
- Registry status
- 800
- Enrollment target
- 2
- Study locations
NCT06668935 is a study of Diabetes Mellitus that is actively recruiting participants, run by Abbott Diabetes Care. The registered enrollment target is 800 participants, below the 1,864-participant average among 208 other Diabetes Mellitus trials with a reported enrollment target (57% lower). The trial reports 2 study locations across 1 state.
The verdict
NCT06668935, a study of Diabetes Mellitus, is actively recruiting participants, sponsored by Abbott Diabetes Care.
- RECRUITING
- Registry status
- 800 participants
- Enrollment target
- 2
- Study locations
Study Summary
This study is to see if the FreeStyle Libre 3 Continuous Glucose Monitoring System (FSL3) will help prolong the length of time people with diabetes maintain adherence to glucagon-like peptide 1 (GLP-1/GIP) agonists.
Conditions Studied
Interventions
- DEVICE To utilize the FreeStyle Libre 3 Continuous Glucose Monitoring System (FSL3) to help prolong the length of time people with diabetes maintain adherence to GLP-1 and dual GIP/GLP-1 agonists
Study Locations (2)
Florida
- East Coast Institute for Research, LLC - Jacksonville
- Excellence Medical and Research - Miami Gardens
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 800 participants |
| Start Date | 2024-10-24 |
| Est. Completion | 2027-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06668935
The ClinicalTrials.gov registry entry for NCT06668935 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 800 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,864-participant average among 208 other Diabetes Mellitus trials with a reported enrollment target (57% lower). The listed sponsor is Abbott Diabetes Care, which has 26 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Diabetes Mellitus appearing as the primary indexed condition, and to 1 intervention - of which To utilize the FreeStyle Libre 3 Continuous Glucose Monitoring System (FSL3) to help prolong the length of time people with diabetes maintain adherence to GLP-1 and dual GIP/GLP-1 agonists is the first listed.
NCT06668935 reports 2 study locations spanning 1 distinct geographic area - top geographies include Florida.
Frequently Asked Questions
What is clinical trial NCT06668935 about?
NCT06668935 is a clinical study titled "Prolongation of GLP-1 Adherence When Using Continuous Glucose Monitoring". This study is to see if the FreeStyle Libre 3 Continuous Glucose Monitoring System (FSL3) will help prolong the length of time people with diabetes maintain adherence to glucagon-like peptide 1 (GLP-1/GIP) agonists.
What is the current status of trial NCT06668935?
This trial is currently recruiting. The enrollment target is 800 participants. The study started on 2024-10-24. Estimated completion is 2027-01.
What conditions does trial NCT06668935 study?
This clinical trial studies the following conditions: Diabetes Mellitus.
What interventions are being tested in trial NCT06668935?
The interventions under investigation include: To utilize the FreeStyle Libre 3 Continuous Glucose Monitoring System (FSL3) to help prolong the length of time people with diabetes maintain adherence to GLP-1 and dual GIP/GLP-1 agonists (DEVICE).
Who is sponsoring clinical trial NCT06668935?
This trial is sponsored by Abbott Diabetes Care, which has 26 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06668935 being conducted?
This trial has 2 study locations across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Diabetes Mellitus
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Genetic Studies of Insulin and Diabetes
RECRUITING
-
Improving Glycemic Control With Telemedicine and Smart Insulin Pens
RECRUITING · NA
-
Family Investigation of Nephropathy and Diabetes (F.I.N.D.)
RECRUITING
-
Genetics Of Autoimmunity In Type I Diabetes
RECRUITING
-
Comparing Healthcare Visit Recording and Open Notes to Improve Chronic iLlness Care Experience in Older Adults
RECRUITING · NA
-
Therapeutic Plantar Electrical Stimulation Intervention During Hemodialysis to Improve Balance and Mobility
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.